/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.03%
Natural Gas
-1.04%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-1.32%
VIX
N/A
Economic Calendar
EUR/USD
+0.03%
Natural Gas
-1.04%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-1.32%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
October Retail Sales Rise 0.4%, Show Resilience Despite Slowing Momentum
3 days ago
China Retail Sales Jumps in October as Unemployment Drops to 5.0%
3 days ago
France’s Economic Strengths Balance Increasingly Challenging Fiscal, Political Outlooks
4 days ago
Crude Inventories Rise By 2.1 Million Barrels, Exceeding Analyst Estimates
4 days ago
October PPI Rises 0.2%, Supporting Fed Rate Cut Hopes as Inflation and Jobs Steady
4 days ago
Disney’s Streaming Fuels Optimism; PPI Data May Forecast Fed’s Next Steps
4 days ago
Silver (XAG) Forecast: Will Dollar Weakness Spark a Rebound?
12 minutes ago
Gold News: Resistance at $2604 Holds the Key to the Next Price Breakout
40 minutes ago
Oil News: Tensions in Ukraine Drive Crude Oil Higher Amid Bearish Market Sentiment
about 1 hour ago
Cryptocurrency Market Analysis: Altcoins Gain Momentum
about 2 hours ago
US Dollar Price Forecast: G20 Meetings in Focus: Gold, GBP/USD, and EUR/USD Outlook
about 3 hours ago
AI, Consumers, and Industrials Collide: Nvidia, Walmart, and Deere Dominate Earnings Week
about 3 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
RARE
news
Ultragenyx Pharmaceutical Inc.
Follow
RARE
(
Nasdaq - US
)
Closed
44.75
-2.89 (-6.08%)
in
:
usd
•
As of: Nov 15, 2024 15:59
UTC -5
Pre Market
:
0
+0.00 (0.00%)
Open
47.50
High
47.67
Low
44.56
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Latest News
Zacks Investment Research
Nov 6, 2024
Ultragenyx Q3 Loss Narrower Than Expected, Revenues Beat Estimates
RARE
-6.08%
Seeking Alpha
Nov 6, 2024
Ultragenyx Pharmaceutical Inc. (RARE) Q3 2024 Earnings Call Transcript
RARE
-6.08%
Zacks Investment Research
Nov 6, 2024
Compared to Estimates, Ultragenyx (RARE) Q3 Earnings: A Look at Key Metrics
RARE
-6.08%
Zacks Investment Research
Nov 5, 2024
Ultragenyx (RARE) Reports Q3 Loss, Tops Revenue Estimates
RARE
-6.08%
Zacks Investment Research
Oct 8, 2024
RARE's Bone Disorder Drug Gets FDA's Breakthrough Therapy Tag
RARE
-6.08%
Zacks Investment Research
Oct 4, 2024
RARE's Wilson Disease Candidate Betters Standard Therapy in Study
RARE
-6.08%
UToday
Sep 13, 2024
Coinbase Premium Sends Super-Rare Bullish Signal for BTC
BITCOIN
-0.06%
SUPERRARE
-2.93%
Seeking Alpha
Aug 22, 2024
Ultragenyx's Strong Pipeline And Valuation Concerns: A Balanced Perspective
RARE
-6.08%
CoinPedia
Aug 18, 2024
Must Buy Ethereum-based Tokens This 2024!
ALTLAYER
-1.59%
SYNAPSE-2
-3.47%
SUPERRARE
-2.93%
CoinPedia
Aug 15, 2024
Three Plus Three for the Win: Six Altcoins to Stack and Why They Could Soar
AVALANCHE-2
-4.25%
BITCOIN
-0.06%
POLKADOT
+3.44%
InvestorPlace
Aug 6, 2024
3 Genomics Stocks That May Transform Personalized Medicine
SRPT
-4.13%
Seeking Alpha
Aug 2, 2024
Ultragenyx Pharmaceutical Inc. (RARE) Q2 2024 Earnings Call Transcript
RARE
-6.08%
Zacks Investment Research
Aug 2, 2024
Ultragenyx (RARE) Q2 Loss Narrower Than Expected, Revenues Up
RARE
-6.08%
Zacks Investment Research
Aug 2, 2024
Compared to Estimates, Ultragenyx (RARE) Q2 Earnings: A Look at Key Metrics
RARE
-6.08%
Zacks Investment Research
Aug 1, 2024
Ultragenyx (RARE) Reports Q2 Loss, Tops Revenue Estimates
RARE
-6.08%
Zacks Investment Research
Jul 25, 2024
Ultragenyx (RARE) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
RARE
-6.08%
Benzinga
Jul 22, 2024
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
IONS
-7.90%
Zacks Investment Research
Jul 18, 2024
Ultragenyx (RARE) Aligns With FDA on Phase III Neuro Study Plans
RARE
-6.08%
The Cryptonomist
Jun 29, 2024
The collapse of the value of NFTs and the comment of the CEO of SuperRare
SUPERRARE
-2.93%
InvestorPlace
Jun 17, 2024
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
NVS
-0.32%
Stocks
Popular
Currencies
Commodities
Indices
Stocks
ETFs
Crypto
Watchlist
Loading
Loading
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker